Simplifying the Patient Experience!
Cole StevensVP of Corporate Developmentcole.stevens@myphm.com
08-17-2020
Interim Consolidated Financial Statements - 2020 | Q3 Ending June 30, 2020/2019
06-24-2020
Amended Interim Consolidated Financial Statements - 2020 | Q2 Ending Mar 31, 2020/2019
05-19-2020
Interim Consolidated Financial Statements - 2020 | Q2 Ending Mar 31, 2020/2019
02-26-2020
Interim Consolidated Financial Statements - 2020 | Q1 Ending Dec 31, 2019/2018
01-28-2020
Final Consolidated Financial Statements | Year Ending Sep 30, 2019/2018
08-19-2019
Interim Consolidated Financial Statements - 2019 | Q3 Ending June 30, 2019/2018
05-21-2019
Interim Consolidated Financial Statements - 2019 | Q2 Ending Mar 31, 2019/2018
02-26-2019
Interim Consolidated Financial Statements - 2019 | Q1 Ending Dec 31, 2018
01-30-2019
Final Consolidated Financial Statements | Year Ending Sep 30, 2018 and Sep 30, 2017
08-28-2018
Interim Consolidated Financial Statements - 2018 | Q3 Ending June 30, 2018 and 2017
05-15-2018
Interim Consolidated Financial Statements - 2018 | Q2 Ending Mar 31, 2018 and 2017
03-01-2018
Interim Consolidated Financial Statements - 2018 | Q1 Ending Dec 31, 2017
Management's Discussion and Analysis - 2020 | Q3 Ending June 30, 2020
Amended Management's Discussion and Analysis - 2020 | Q2 Ending Mar 31, 2020
Management's Discussion and Analysis - 2020 | Q2 Ending Mar 31, 2020
Management's Discussion and Analysis - 2020 | Q1 Ending Dec 31, 2019
Management's Discussion and Analysis | Year Ending Sep 30, 2019 and Sep 30, 2018
Management's Discussion and Analysis - 2019 | Q3 Ending June 30, 2019
Management's Discussion and Analysis - 2019 | Q2 Ending Mar 31, 2019
Management's Discussion and Analysis - 2019 | Q1 Ending Dec 31, 2018
Management's Discussion and Analysis | Year Ending Sep 30, 2018 and Sep 30, 2017
Management's Discussion and Analysis - 2018 | Q3 Ending June 30, 2018
Management's Discussion and Analysis - 2018 | Q2 Ending Mar 31, 2018
Management's Discussion and Analysis - 2018 | Q1 Ending Dec 31, 2017